Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neiyaku Kagaku (Neiyaku Chemical Industry) is a Japanese pharmaceutical company headquartered in Nara, Japan, specializing in the development, manufacturing, and contract manufacturing (OEM/ODM) of over-the-counter (OTC) drugs, quasi-drugs, and health supplements. Founded in 1940, the company produces a wide range of solid dosage products, including vitamins, Kampo (traditional herbal) medicines, and consumer healthcare products such as Ryoushin JV tablets for joint pain and Kimie White for skin spots. Neiyaku Kagaku operates GMP-compliant manufacturing facilities, including its main factory in Yamatotakada and the newly completed Shinjo packaging plant in Katsuragi, which was completed in 2026. The company provides comprehensive services from product planning and formulation development to raw material purification, tableting, coating, and packaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neiyaku Kagaku.